Evox raises £35m for exosome therapeutics by Selina McKee | Sep 3, 2018 | News | 0 Oxford, UK-based Evox Therapeutics has raised £35 million to help advance its exosome-based therapeutics pipeline. Read More
£13m Oxford partnership to accelerate drug innovations by Selina McKee | Nov 10, 2016 | News | 0 Oxford University, Oxford University Innovation (OUI), Oxford Sciences Innovation (OSI) and Evotec have formed a new public-private alliance to help progress the development of new medicines stemming from Oxford research. Read More